StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)

Close on Nov 18, 2026Market cap $7.15MP/E –Yield –

Quoin Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2021 it was $0.

Annual revenue

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0–
FY2020Dec 31, 2020$0–
FY2019Dec 31, 2019$0–

More Quoin Pharmaceuticals figures

See a number that looks wrong?